Table 1. Differences of clinical and biochemical parameters in hemodialysis patients between abdominal obesity and non-abdominal obesity.
| Patients with abdominal obesity (n = 93) | Patients not with abdominal obesity (n = 111) | P value | |
| Age (years) | 64.8±11.7 | 62.3±14.0 | 0.164 |
| Male (%) | 35 (37.6%) | 63 (56.8%) | 0.006 |
| HD years | 4.3±3.8 | 4.6±4.0 | 0.607 |
| Body mass index (kg/m2) | 25.1±3.0 | 20.6±3.1 | <0.001 |
| SBP (mmHg) | 137.8±19.0 | 141.3±16.1 | 0.158 |
| DBP (mmHg) | 74.6±8.0 | 76.8±7.4 | 0.037 |
| Smoking | 13 (14.0%) | 11 (9.9%) | 0.369 |
| HCV infection (%) | 48 (51.6%) | 49 (44.1%) | 0.287 |
| Diabetes | 50 (53.8%) | 55(49.5%) | 0.549 |
| PAD | 25 (26.9%) | 12 (10.8%) | 0.003 |
| Albumin (g/dl) | 3.8±0.4 | 3.9±0.4 | 0.526 |
| Hemoglobulin (mg/dl) | 10.3±1.6 | 10.2±1.6 | 0.873 |
| GPT (U/L) | 18.6±9.4 | 25.4±41.3 | 0.093 |
| Fasting blood glucose (mg/dl) | 120.8±68.7 | 119.2±59.9 | 0.865 |
| Uric acid (mg/dl) | 7.5±1.5 | 7.2±1.3 | 0.057 |
| Insulin (µIU/ml) | 28.1±33.1 | 18.8±25.3 | 0.029 |
| C-Peptide | 14.0±8.4 | 10.7±8.5 | 0.007 |
| HOMA-IR | 9.2±12.0 | 5.2±5.2 | 0.004 |
| Total Cholesterol (mg/dl) | 170.2±41.7 | 162.8±32.7 | 0.166 |
| Triglyceride (mg/dl) | 179.4±134.3 | 141.2±83.2 | 0.018 |
| HDL-cholesterol (mg/dl) | 41.9±12.4 | 47.6±17.3 | 0.008 |
| LDL-cholesterol (mg/dl) | 99.7±28.8 | 92.4±22.4 | 0.045 |
| Ln-hsCRP (mg/dL) | 1.5±1.3 | 1.1±1.2 | 0.021 |
| Ln-Adiponectin (pg/mL) | 5.6±0.3 | 5.7±0.3 | 0.008 |
| Ln-IL-6 | 2.9±0.9 | 2.9±1.1 | 0.958 |
| Ln-TNF-α(pg/mL) | 0.9±1.0 | 1.0±0.9 | 0.415 |
| Ln-ADMA (pg/mL) | 3.2±0.4 | 3.3±4.2 | 0.103 |
| Kt/V | 1.81±0.29 | 1.81±0.34 | 0.939 |
| ABI | 0.96±0.23 | 1.08±0.16 | <0.001 |
| PWV (m/s) | 17.9±5.5 | 18.4±4.4 | 0.476 |